Security key
000899104
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 238,388,839
- Total 13F shares
- 6,949,700
- Share change
- +973,746
- Total reported value
- $32,778,360
- Price per share
- $9.80
- Number of holders
- 18
- Value change
- +$9,198,949
- Number of buys
- 14
- Number of sells
- 5
Report period
Q1 2015
Institutions
18
Top holders
10
ADMA full security history
Newer quarter: Q2 2015
Previous quarter: Q4 2014
ADMA BIOLOGICS, INC. SEC filings
ADMA BIOLOGICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 000899104
Recent filing periods:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$40,303 | — | 31 Dec 2014 | |
| Consonance Capital Management LP |
13F
|
Company |
0.37%
|
877,407
|
$9,801,000 | — | 31 Dec 2014 | |
| FMR LLC |
13F
|
Company |
0.18%
|
423,100
|
$4,726,000 | — | 31 Dec 2014 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.16%
|
389,193
|
$4,347,000 | — | 31 Dec 2014 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.15%
|
360,137
|
$4,023,000 | — | 31 Dec 2014 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.1%
|
245,930
|
$2,747,000 | — | 31 Dec 2014 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.03%
|
67,066
|
$749,000 | — | 31 Dec 2014 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
2,000
|
$22,000 | — | 31 Dec 2014 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,600
|
$18,000 | — | 31 Dec 2014 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
650
|
$7,000 | — | 31 Dec 2014 | |
| REGENTATLANTIC CAPITAL LLC |
13F
|
Company |
0%
|
500
|
$5,585 | — | 31 Dec 2014 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
200
|
$2,000 | — | 31 Dec 2014 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q1 2015
As of 31 Mar 2015,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,949,700 shares.
The largest 10 holders included
Aisling Capital LLC, Consonance Capital Management LP, Broadfin Capital, LLC, FMR LLC, FRANKLIN RESOURCES INC, PointState Capital LP, J. Goldman & Co LP, Telemetry Investments, L.L.C., Weiss Multi-Strategy Advisers LLC, and Alyeska Investment Group, L.P..
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2015 vs Q4 2014 Across Filers
Q4 2014 holders
11
Q1 2015 holders
18
Holder diff
7
| Investor | Q4 2014 Shares | Q1 2015 Shares | Share Diff | Share Chg % | Q4 2014 Value $ | Q1 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.